Post on 23-Jul-2020
A Development of Chimeric VEGFR2 TK Inhibitor Based on Two
Ligand Conformers from PDB: 1Y6A Complex - Medicinal
Chemistry Consequences of a TKs Analysis
Lucia Lintnerová,a Melissa García-Caballero,b Fridrich Gregáň,c Milan Melicherčík,c Ana R.
Quesada,b Juraj Dobiaš,a Ján Lác,d Marta Sališová,a and Andrej Boháč,a,d*
a Comenius University, Faculty of Natural Sciences, Department of Organic Chemistry, Mlynská dolina 842 15,
Bratislava, Slovakia, andrej.bohac@fns.uniba.sk, phone: +421260296409, fax: +421260296337b Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, Universidad de Málaga, Campus de
Teatinos, 29071-Málaga, Spain. Tel. 34(9)52137128, Fax. 34(9)52132000, quesada@uma.esc Matej Bel University, Faculty of Natural Sciences, Department of Chemistry Tajovského 40, 974 01 Banská
Bystrica, Slovakia, fridrich.gregan@umb.sk, milan.melichercik@umb.skd Biomagi, Inc., Mamateyova 26, 851 04 Bratislava, Slovakia, phone: +421902522144
1
Representative 1H and 13C NMR spectra possessing spectral maps
2
3
4
5
6
7
8
9
10
11
12
13